Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dion Chavis

Plastic and Reconstructive Surgery Indianapolis, IN Medical Doctor

NPI 1982770285 CMS profile 1131597

9002 North Meridian Street, Suite 104, Indianapolis, IN 46260

Open in the dashboard

General payments

$15,051

36 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dion Chavis of Indianapolis, IN is reported in the CMS Open Payments database as having received $15,051 across 36 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $39 2
2023 General $17 1
2022 General $17 1
2021 General $62 4
2020 General $812 2
2019 General $14,105 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dion Chavis
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Dion Chavis were reported at $39. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Dion Chavis Plastic and Reconstructive Surgery median Middle half National median
2019 $14,105 $335 $121–$1,264 $163
2020 $812 $162 $57–$417 $114
2021 $62 $245 $89–$735 $132
2022 $17 $325 $120–$932 $149
2023 $17 $343 $129–$999 $160
2024 $0 $390 $141–$1,085 $164
2025 $39 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organogenesis Inc. $14,905 27 payments
  2. Misonix Inc $74 5 payments
  3. Mentor Worldwide LLC $25 1 payment
  4. Abbott Laboratories $17 1 payment
  5. Zimmer Biomet Holdings, Inc. $17 1 payment
  6. Shield Therapeutics Inc $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,089 25 payments
  2. Honoraria $800 1 payment
  3. Food and Beverage $162 10 payments
Products named General payments · program years 2019–2025
  1. Apligraf Podiatry $14,089 25 payments
  2. Dermagraft $14,089 25 payments
  3. Puraply/Affinity/NuTech $14,089 25 payments
  4. Puraply $800 1 payment
  5. MENTOR MemoryGel Resterilizable Gel Sizer $25 1 payment
  6. FreeStyle Libre 2 $17 1 payment
  7. Gel-One Cross-linked Hyaluronate $17 1 payment
  8. Apligraf Wound Care $16 1 payment
  9. ACCRUFER $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

121

Median for General Surgery: 59

Drug cost

$847

Median for General Surgery: $393

Branded share of claims

34.7%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 12 $254
Cephalexin Generic 30 $238
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 42 $211
Ondansetron Hcl Generic 37 $145

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Records

36 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record